Cart
sales@molnova.com
MK-2295
CAS No. 878811-00-8
MK-2295( MK2295 | MK 2295 )
Catalog No. M27996 CAS No. 878811-00-8
MK-2295 is a potent TRPV1 antagonist. MK-2295 can be used in studies about the treatment of chronic pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 149 | In Stock |
|
| 10MG | 220 | In Stock |
|
| 25MG | 337 | In Stock |
|
| 50MG | 462 | In Stock |
|
| 100MG | 619 | In Stock |
|
| 200MG | 835 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-2295
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-2295 is a potent TRPV1 antagonist. MK-2295 can be used in studies about the treatment of chronic pain.
-
DescriptionMK-2295 is a potent TRPV1 antagonist. MK-2295 can be used in studies about the treatment of chronic pain.
-
In Vitro——
-
In Vivo——
-
SynonymsMK2295 | MK 2295
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorJAK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number878811-00-8
-
Formula Weight490.583
-
Molecular FormulaC27H31FN6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@H]1CCCN1c1nc(cc(n1)-c1ccc(F)cc1)N1CCN(C[C@H]1C)c1ncc(cc1C)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Paul Smith, et al. Use of jak1 inhibitors for the treatment of cutaneous lupus erythematosus and lichen planus (lp). WO2021076124A1.
molnova catalog
related products
-
FEMA-4809
FEMA-4809, a highly potent TRPM8 receptor activator, TRPM8 is the ion channel responsible for the cool perception.
-
AM404
AM404 is an endocannabinoid reuptake inhibitor, a TRPV(1) activator, a paracetamol metabolite, with neuroprotective and anticancer activity that blocks anandamide transport.
-
RN-1747
RN-1747 is a selective transient receptor potential cation channel subfamily V member 4 agonists (EC50: hTRPV4 of 0.77 μM, mTRPV4 of 4.0 μM, and rTRPV4 of 4.1 μM). RN-1747 also antagonizes TRPM8 (IC50: 4 μM).
